Consumer Health

Herbal/traditional products saw healthy current value growth in the review period, and this is set to continue in 2023 due to several factors. During the pandemic, jamu, or Indonesian herbal medicine, was one of the options chosen by consumers to…

Paediatric consumer health is set to remain one of the better performing categories in consumer health in 2023, with the expectation of solid current value growth and also continued volume growth, despite the falling population aged 0-12. This is due…

In 2023, sleep aids is set to maintain positive retail volume and current value growth. Different ages have different needs when it comes to sleep; for example, younger children need around 10 hours of sleep, teenagers eight hours, adults six hours,…

Millennials and Gen Z increasingly prioritise their wellbeing and wellness, which is set to contribute to retail volume and current value growth for sports nutrition in 2023. Rising health awareness can be seen through the massive expansion of gym…

In 2023, overall vitamins is expected to maintain current value growth, although volume sales are set to turn to decline. However, this is unlikely to be part of a larger trend, as a return to growth is expected in the forecast period. It is more…

In 2023, weight management and wellbeing is set to see continued retail volume and current value growth. The positive performance of the category is expected to be triggered by several factors. For instance, based on the latest data released by the…

Wound care is set to see slow retail volume growth in 2023, along with slightly higher current value growth. Local consumers tend to use sticking plasters as a first recourse for treating slight punctures, cuts, and other wounds. Some parents carry…

Analgesics is expected to register moderate constant value growth in 2023. High inflation is continuing to have an effect and consumers are expected to be highly price sensitive and prioritise value for money. That being said, inflation is easing in…

Analgesics is set to see a decline in sales in 2023 as consumers have migrated away from aspirin in an uncertain economic environment and sought to prioritise household essentials, while turning to other categories to treat basic ailments such as…

Analgesics is projected to continue to post fast retail volume growth over 2023. The potential for even higher growth is restricted by many households retaining stocks of analgesics purchased during the Coronavirus (COVID-19) pandemic. One clear…

In 2023, Cambodia seems to have recovered from the COVID-19 pandemic. Meanwhile, consumer health demand is rising due to modernisation, urbanisation, and health risks from harmful chemicals. Nonetheless, challenges still exist, such as external…

Consumer health is expected to register moderate constant value growth in 2023. Continuing economic uncertainty as a result of Russia’s invasion of Ukraine and high inflation is continuing to have an effect and consumers are expected to be highly…

Consumer health has seen demand dampened by consumers being confronted with very high inflation. The rate of 9.2% in 2022 was the highest experienced in decades. As a result, more consumers have been forced to prioritise household spending on…

Consumer health in Honduras experienced a year of growth in value terms in 2023 that was in line with the country's inflation. Categories such as analgesics, cough, cold and allergy (hay fever) remedies, dermatologicals, and sports nutrition…

In general, consumer health in Kazakhstan is performing well towards the end of the review period. However, high inflation, increases in the costs of raw materials for the production of medicines and changed or disrupted logistics/supply routes have…

The harsh climatic conditions in Kuwait with extreme heat, rising pollution and large amounts of dust continue to play a key role in driving demand across key OTC categories, in particular analgesics and cough, cold and allergy (hay fever) remedies.…

Analgesics is expected to register moderate constant value growth in 2023. Though there was widespread severe flu in early 2023, cough and cold remedies are not expected to benefit to a huge degree, as most of these patients were hospitalised or put…

Cough, cold and allergy (hay fever) remedies are widely consumed consumer health items in the Guatemalan market. These products have established broad distribution throughout the country, with products available throughout the modern and traditional…

Cough, cold and allergy (hay fever) remedies is experiencing a level of stabilisation in 2023. Following strong retail volume growth in the wake of the Coronavirus (COVID-19) pandemic, almost all categories are projected to see slower retail volume…

Dermatologicals is expected to register moderate constant value growth in 2023. Geopolitical tensions in the region have led to a significant increase in the number of immigrants from Ukraine, Russia and Belarus, and this is expected to contribute to…